Hims & Hers

Hims & Hers, founded in 2017 and publicly traded on the New York Stock Exchange under the ticker HIMS, operates a health and wellness telehealth platform that connects consumers with licensed healthcare providers. The company's technical work spans telehealth, digital health platforms, direct-to-consumer e-commerce, prescription fulfilment and delivery, lab testing and diagnostics, and personalised care and treatment. It has raised over $200 million in funding and is present in the United States, with global expansion planned.

The platform functions as a virtual front door to the healthcare system, providing consultations, diagnosis and ongoing support from the home. Its service lines include hair loss, sexual health, weight management, mental health and primary care, alongside comprehensive lab testing and the fulfilment and delivery of prescription and over-the-counter medications from diagnosis to delivery. The telehealth consultation product serves millions of consumers.

Hims & Hers describes itself as one of the fastest-growing direct-to-consumer brands in history. The company states a mission to help people feel better through improved health, with an emphasis on convenient, affordable and accessible treatment delivered in the home and on normalising conversations about sensitive health issues.